# Mercia Diagnostics, Ltd.

- Location (FDA's records): Guildford, Surrey England, GB
- FDA decisions: 17 (1987–1992): 17 510(k) clearances
- Product codes: LIP (4), LGD (3), LFZ (3), JWZ (2), LFX (2), GOB (1), LRF (1), LIQ (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 1 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Incstar Corp.: 1 (https://510kreport.com/company/incstar)
- Diagnostic Products Corp.: 1 (https://510kreport.com/company/diagnostic-products)

## Its most-cited devices
- K896295: Captia (R) CMV-M (1990), cited by 1
- K885300: Captia (R) Rubella-M (1989), cited by 1

## Recent decisions
- K915479: Captia CMV-TA (May 4, 1992)
- K904524: Captia (R) Syphilis M, Modification (Dec 26, 1990)
- K900654: Modified Captia (R) Syphilis-M (Mar 8, 1990)
- K900655: Modified Captia (R) Toxo-M (Mar 6, 1990)
- K896295: Captia (R) CMV-M (Mar 6, 1990)
- K896194: Captia (R) CMV-G (Mar 6, 1990)
- K883924: Captia (R) Rubella-G (Aug 15, 1989)
- K885300: Captia (R) Rubella-M (Aug 15, 1989)

Source page: https://510kreport.com/company/mercia-diagnostics